• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者循环系统中肠道微生物代谢产物的改变。

Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.

机构信息

Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.

Department of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.

出版信息

J Parkinsons Dis. 2022;12(4):1219-1230. doi: 10.3233/JPD-223179.

DOI:10.3233/JPD-223179
PMID:35342048
Abstract

BACKGROUND

Emerging evidence suggests that gut dysbiosis contributes to Parkinson's disease (PD) by signaling through microbial metabolites. Hippuric acid (HA), indole derivatives, and secondary bile acids are among the most common gut metabolites.

OBJECTIVE

To examine the relationship of systemic concentrations of these microbial metabolites associated with changes of gut microbiota, PD status, and severity of PD.

METHODS

We enrolled 56 patients with PD and 43 age- and sex-matched healthy participants. Motor and cognitive severity were assessed with Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III motor score and the Mini-Mental State Examination (MMSE), respectively. Plasma concentrations of targeted gut metabolites were measured with liquid chromatography-tandem mass spectrometry. Gut microbiota was analyzed with shotgun metagenomic sequencing.

RESULTS

Compared with controls, PD patients had significantly higher plasma levels of HA, indole-3-propionic acid (IPA), deoxycholic acid (DCA), and glycodeoxycholic acid (GDCA). After adjustment for age and sex in a multivariate logistic regression analysis, plasma levels of HA (odds ratio [OR] 3.21, p < 0.001), IPA (OR 2.59, p = 0.031), and GDCA (OR 2.82, p = 0.036) were associated with positive PD status. Concentrations of these gut metabolites did not correlate with MDS-UPDRS part III score or MMSE after adjustment for confounders. Microbial metabolite levels were associated with the relative abundance of pro-inflammatory gut bacteria.

CONCLUSION

Aberrant gut microbial metabolites of HA, indole derivatives and secondary bile acids associated with specific gut microbiota changes were observed in patients with PD.

摘要

背景

有新证据表明,肠道菌群失调通过微生物代谢产物发出信号,从而导致帕金森病(PD)。马尿酸(HA)、吲哚衍生物和次级胆汁酸是最常见的肠道代谢物之一。

目的

研究与肠道微生物群变化、PD 状态和 PD 严重程度相关的这些微生物代谢产物的系统浓度的关系。

方法

我们纳入了 56 名 PD 患者和 43 名年龄和性别匹配的健康参与者。使用运动障碍协会统一帕金森病评定量表(MDS-UPDRS)第三部分运动评分和简易精神状态检查(MMSE)分别评估运动和认知严重程度。使用液相色谱-串联质谱法测量靶向肠道代谢物的血浆浓度。使用 shotgun 宏基因组测序分析肠道微生物群。

结果

与对照组相比,PD 患者的 HA、吲哚-3-丙酸(IPA)、脱氧胆酸(DCA)和甘氨脱氧胆酸(GDCA)的血浆水平明显更高。在多元逻辑回归分析中,调整年龄和性别后,HA(优势比 [OR] 3.21,p < 0.001)、IPA(OR 2.59,p = 0.031)和 GDCA(OR 2.82,p = 0.036)的血浆水平与 PD 阳性状态相关。在调整混杂因素后,这些肠道代谢物的浓度与 MDS-UPDRS 第三部分评分或 MMSE 不相关。微生物代谢产物水平与促炎肠道细菌的相对丰度相关。

结论

在 PD 患者中观察到与特定肠道微生物群变化相关的 HA、吲哚衍生物和次级胆汁酸等异常肠道微生物代谢物。

相似文献

1
Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.帕金森病患者循环系统中肠道微生物代谢产物的改变。
J Parkinsons Dis. 2022;12(4):1219-1230. doi: 10.3233/JPD-223179.
2
Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.短链脂肪酸的粪便和血浆水平与帕金森病患者的肠道微生物群和临床严重程度的关联。
Neurology. 2022 Feb 22;98(8):e848-e858. doi: 10.1212/WNL.0000000000013225. Epub 2022 Jan 7.
3
Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.帕金森病患者血清短链脂肪酸及其与运动和非运动症状的相关性。
BMC Neurol. 2022 Jan 7;22(1):13. doi: 10.1186/s12883-021-02544-7.
4
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.肠道微生物失调与帕金森病中的微生物代谢产物。
Ageing Res Rev. 2018 Aug;45:53-61. doi: 10.1016/j.arr.2018.04.004. Epub 2018 Apr 26.
5
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.帕金森病患者的肠道微生物群改变和炎症细胞因子反应。
J Neuroinflammation. 2019 Jun 27;16(1):129. doi: 10.1186/s12974-019-1528-y.
6
Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson's Disease.血浆脂多糖结合蛋白反映帕金森病的风险和进展。
J Parkinsons Dis. 2021;11(3):1129-1139. doi: 10.3233/JPD-212574.
7
Dysbiosis of gut microbiota in a selected population of Parkinson's patients.特定帕金森病患者人群的肠道微生物失调。
Parkinsonism Relat Disord. 2019 Aug;65:124-130. doi: 10.1016/j.parkreldis.2019.06.003. Epub 2019 Jun 3.
8
Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.肠道微生物群和微生物代谢物在帕金森病中的潜在作用。
Ageing Res Rev. 2021 Aug;69:101347. doi: 10.1016/j.arr.2021.101347. Epub 2021 Apr 24.
9
Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease.肠道微生物群失调与帕金森病中胆汁酸升高有关。
Metabolites. 2021 Jan 4;11(1):29. doi: 10.3390/metabo11010029.
10
Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson's Disease.宏基因组分析揭示帕金森病中肠道微生物组的大规模紊乱。
Mov Disord. 2024 Oct;39(10):1740-1751. doi: 10.1002/mds.29959. Epub 2024 Aug 28.

引用本文的文献

1
Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection.微生物群衍生的色氨酸代谢产物吲哚 - 3 - 丙酸在神经保护中的新作用。
Molecules. 2025 Sep 5;30(17):3628. doi: 10.3390/molecules30173628.
2
The fecal metabolome and microbiome are altered in dogs with idiopathic epilepsy compared to healthy dogs.与健康犬相比,特发性癫痫犬的粪便代谢组和微生物群发生了改变。
Sci Rep. 2025 Jul 25;15(1):27024. doi: 10.1038/s41598-025-09919-7.
3
Enrichment of gut-derived metabolites in a Parkinson's disease subtype with REM sleep behavior disorder.
快速眼动睡眠行为障碍型帕金森病亚型中肠道衍生代谢物的富集
NPJ Parkinsons Dis. 2025 Jul 1;11(1):189. doi: 10.1038/s41531-025-01040-w.
4
The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies.微生物群-肠-脑轴与中枢神经系统疾病:从发病机制到治疗策略
Front Microbiol. 2025 Jun 13;16:1583562. doi: 10.3389/fmicb.2025.1583562. eCollection 2025.
5
Gut microbiome-driven regulation of sex hormone homeostasis: a potential neuroendocrine connection.肠道微生物群驱动的性激素稳态调节:一种潜在的神经内分泌联系。
Gut Microbes. 2025 Dec;17(1):2476562. doi: 10.1080/19490976.2025.2476562. Epub 2025 Mar 12.
6
Gut microbial metabolism in Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症的肠道微生物代谢。
Neurotherapeutics. 2024 Oct;21(6):e00470. doi: 10.1016/j.neurot.2024.e00470. Epub 2024 Oct 28.
7
The Neuroprotective Role of Indole-3-Propionic Acid in Migraine Pathophysiology.色胺-3-丙酸在偏头痛发病机制中的神经保护作用。
Medicina (Kaunas). 2024 Aug 30;60(9):1417. doi: 10.3390/medicina60091417.
8
Towards a better understanding of idiopathic epilepsy through metabolic fingerprinting of cerebrospinal fluid in dogs.通过对犬脑脊液进行代谢指纹图谱分析,以期更好地了解特发性癫痫。
Sci Rep. 2024 Jun 26;14(1):14750. doi: 10.1038/s41598-024-64777-z.
9
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.通过靶向肠道微生物组治疗神经退行性疾病:从实验室到临床。
Transl Neurodegener. 2024 Feb 27;13(1):12. doi: 10.1186/s40035-024-00404-1.
10
Kathrin Brockmann, Milan Zimmermann, and Dareia Roos, Recipients of The Parkinson Prize 2023.卡特琳·布罗克曼、米兰·齐默尔曼和达雷亚·罗斯,2023年帕金森奖获得者。
J Parkinsons Dis. 2023;13(8):1273-1276. doi: 10.3233/JPD-239006.